We are live on ! Find out more
VRTX icon

Vertex Pharmaceuticals
VRTX

376 hedge funds and large institutions have $17.1B invested in Vertex Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 376 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more call options, than puts

Call options by funds: $419M | Put options by funds: $287M

Holders
376
Holders Change
+376
Holders Change %
–
% of All Funds
12.27%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.23%
New
376
Increased
–
Reduced
–
Closed
–
Calls
$419M
Puts
$287M
Net Calls
+$131M
Net Calls Change
+$131M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Lord, Abbett & Co
76
Lord, Abbett & Co
New Jersey
$25M +$23M +312,996 New
D.E. Shaw & Co
77
D.E. Shaw & Co
New York
$24.4M +$22.5M +305,517 New
Fidelity International
78
Fidelity International
Bermuda
$24.4M +$22.5M +304,900 New
MTB
79
Mizuho Trust & Banking
Japan
$23.9M +$22.1M +299,588 New
Prudential Financial
80
Prudential Financial
New Jersey
$23.8M +$22M +298,460 New
Morgan Stanley
81
Morgan Stanley
New York
$22.3M +$20.5M +278,961 New
Manulife (Manufacturers Life Insurance)
82
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$22.3M +$20.5M +278,795 New
APG Asset Management
83
APG Asset Management
Netherlands
$21.6M +$19.9M +270,435 New
ZCI
84
Zevenbergen Capital Investments
Washington
$21.5M +$19.8M +268,750 New
Retirement Systems of Alabama
85
Retirement Systems of Alabama
Alabama
$21.2M +$19.6M +265,952 New
Arrowstreet Capital
86
Arrowstreet Capital
Massachusetts
$21M +$19.4M +263,030 New
Millennium Management
87
Millennium Management
New York
$20.8M +$19.1M +259,941 New
BJ
88
BlackRock Japan
Japan
$20.6M +$19M +257,505 New
PA
89
Perceptive Advisors
New York
$20.5M +$18.9M +256,547 New
WF
90
Welch & Forbes
Massachusetts
$20.1M +$18.5M +250,598 New
TPSF
91
Texas Permanent School Fund
Texas
$19.8M +$18.3M +248,261 New
SC
92
Scotia Capital
Ontario, Canada
$19.6M +$18.1M +245,479 New
U
93
UBS
Switzerland
$19.4M +$17.8M +242,081 New
Swiss National Bank
94
Swiss National Bank
Switzerland
$18.5M +$17.1M +232,209 New
PAMU
95
Pictet Asset Management (UK)
United Kingdom
$18.4M +$16.9M +229,807 New
State of Wisconsin Investment Board
96
State of Wisconsin Investment Board
Wisconsin
$18.3M +$16.8M +228,641 New
MSA
97
Mason Street Advisors
Wisconsin
$17.9M +$16.5M +223,537 New
O
98
OrbiMed
New York
$17.9M +$16.4M +223,000 New
Federated Hermes
99
Federated Hermes
Pennsylvania
$17.8M +$16.5M +223,380 New
Susquehanna International Group
100
Susquehanna International Group
Pennsylvania
$15.2M +$14M +190,158 New
2 3
4
5 6

VRTX Hedge Fund Activity: Q2 2013 in Review

376 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Vertex Pharmaceuticals (VRTX) for Q2 2013, worth a combined $17.1B.

Buyers outnumbered sellers: 376 funds opened new VRTX positions and 0 closed out — a net gain of 376 holders — while 0 added to existing stakes and 0 trimmed.

  • 376 institutional investors held Vertex Pharmaceuticals (VRTX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17.1B of Vertex Pharmaceuticals stock for Q2 2013.
  • 376 funds opened new Vertex Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +376 holders.

Based on aggregated 13F filings for Q2 2013.